Key Points of this Study:
• Worldwide, the elderly are the fastest growing seg1nent of the population. As a consequence, the number of cases of age-related cognitive decline and neurological diseases associated with aging, such as Alzheimer’s and Parkinson’s, has been increasing.
• Among the non-pharmacological interventions studied for the treatment or prevention of age-related neurocognitive impairment, photobiomodulation (PBM) has gained prominence for its beneficial effects on brain functions relevant to aging brains.
• Studies using both animals and humans have shown promising metabolic and hemodynamic effects of PBM on the brain, such as improved mitochondrial and vascular functions.
• Studies in humans have shown that PBM can improve electrophysiological activity and cognitive functions such as attention, learning, memory and mood in older people.
There is much to be learned moving forward with PBM and its effects on the aging brain. Studies are underway and include using this therapy for traumatic brain injury, memory, dementia, Alzheimer’s, Autistic disorders and Parkinson’s Disease.
Fabrizio dos Santos Cardoso” t>, F. Gonzalez-Lima h, Sergio Gomes da Silva” 0•1
4Ntu.:lco de Pesqmsas Ternol6gicai;, Uniwrs1daue de Mogi
